Cardiac Pathways searches for new financial strategy as it breaches bank loan conditions
This article was originally published in Clinica
Executive Summary
Cardiac Pathways, a pioneer in minimally-invasive integrated mapping and ablation systems for cardiac tachyarrhythmias, has breached the conditions of its bank loans and has hired Morgan Stanley as financial adviser to pursue strategic alternatives for its future. These include finding new capital for the Sunnyvale, California company, or selling it.